In particular, the Agency considers that sufficient efficacy as required by Article 19(1), point (b)(i), of Regulation (EU) No 528/2012 is not shown due to the lack of relevant efficacy studies demonstrating sufficient efficacy at the intended concentration under required conditions. In addition, it could not be concluded that the physical and chemical properties of the biocidal product family have been determined and deemed acceptable for the purpose of the appropriate use and transport of the products in accordance with Article 19(1), point (d), of Regulation (EU) No 528/2012, with regard to acidity/alkalinity, long term storage stability, degree of dissolution and dilution stability, and due to a lack of information allowing for a conclusion on the corrosiveness to metals and on the auto-ignition temperature for the biocidal product family. Due to the missing data on the efficacy and physico-chemical properties, it is considered that information for the relevant use of the products has not been submitted in accordance with Article 20 of Regulation (EU) No 528/2012, as required by Article 19(3) of that Regulation. The conditions for the authorisation of a biocidal product family laid down in Article 19(6) of Regulation (EU) No 528/2012 are not considered to be fulfilled since sufficient efficacy of the biocidal product family ‘BPF H2O2 HAG’ was not proven for the intended use. The Agency therefore proposes not to authorise the biocidal product family ‘BPF H2O2 HAG’.
Recital 6, Decision_act (EU) 2024/2946
In force